Skip to main content
SPRB logo

SPRB · Spruce Biosciences, Inc.

$42.28 -2.71 (-6.02%) At close · Jul 24
Market Cap
$118.57M
Shares
2.75M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Javier Szwarcberg $2,910,573
Samir Gharib $1,473,211
Kirk Ways $1,044,412
Fiscal 2024
Executive Total
Javier Szwarcberg $1,532,187
Ralph William Charlton III $1,161,336
Samir Gharib $929,690
Fiscal 2023
Executive Total
Javier Szwarcberg $2,157,418
Samir Gharib $1,201,066
Ralph William Charlton III $1,004,904
Fiscal 2022
Executive Total
Javier Szwarcberg $4,490,855
Samir Gharib $975,361
Ralph William Charlton III $962,358
Michael Grey $99,700
Fiscal 2021
Executive Total
Richard King $5,106,007
Samir Gharib $2,194,295
Rosh Dias $1,105,614
Michael Grey $732,303
Javier Szwarcberg
Ralph William Charlton III
Fiscal 2020
Executive Total
Richard King $2,467,526
Rosh Dias $1,680,448
Samir Gharib $793,384
Michael Grey $622,888
Fiscal 2019
Executive Total
Richard King $549,766
Rosh Dias
Samir Gharib
Key facts CIK 1683553 CUSIP 85209E208 13F (30d) 3 filings 3 filers Visit website Investor relations